SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011876
Filing Date
2018-08-14
Accepted
2018-08-14 17:01:26
Documents
62
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 494220
2 ex31-1.htm EX-31.1 19829
3 ex31-2.htm EX-31.2 20363
4 ex32-1.htm EX-32.1 8424
5 ex32-2.htm EX-32.2 8486
  Complete submission text file 0001493152-18-011876.txt   3554180

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE heb-20180630.xml EX-101.INS 604798
7 XBRL SCHEMA FILE heb-20180630.xsd EX-101.SCH 56453
8 XBRL CALCULATION FILE heb-20180630_cal.xml EX-101.CAL 57360
9 XBRL DEFINITION FILE heb-20180630_def.xml EX-101.DEF 154561
10 XBRL LABEL FILE heb-20180630_lab.xml EX-101.LAB 366331
11 XBRL PRESENTATION FILE heb-20180630_pre.xml EX-101.PRE 239543
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-27072 | Film No.: 181018620
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1